Salutations from San Diego. This is Jonathan Wosen, West Coast biotech & life sciences reporter. We’ve got an outstanding lineup for you today, featuring a look...
Earlier this year the startup Doctronic launched a provocative, first-in-the-nation experiment to renew drug prescriptions with a chatbot. Now it’s refilling its coffers with $40 million...
Insmed said Monday that the addition of its drug Arikayce to a standard treatment for patients with a rare bacterial lung disease improved respiratory symptoms and...
An experimental vaccine from Pfizer and Valneva reduced the risk of developing Lyme disease by more than 70%, according to newly released data. Though results appear...
An experimental, long-acting treatment for eczema from Apogee Therapeutics induced skin and itch relief comparable to current, widely used medicines but with less frequent injections, a...
After OpenAI and Anthropic launched dedicated health care initiatives in January, a study published in February found that OpenAI’s ChatGPT Health had a 50% error rate, incorrectly recommending that care be delayed in emergency test cases...
Her son had been sick for four months when Blanca Morales started asking about a transplant. It had started with a case of strep throat from...
The escalating war in the Middle East so far has not appreciably disrupted global pharmaceutical supply chains, but with no clear end in sight, the potential...
It can come seemingly out of nowhere: a patient gets an infection — in the lungs, bladder, or pretty much anywhere — and the body’s immune...
At first glance, it’s a plum job that touches the lives of every American: director of the Centers for Disease Control and Prevention, running the sprawling...
Scan to Read